We are live on ! Find out more
ACOR

Acorda Therapeutics
ACOR

Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

175 hedge funds and large institutions have $899M invested in Acorda Therapeutics in 2016 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 59 increasing their positions, 57 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 18

5% more funds holding

Funds holding: 167 → 175 (+8)

4% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 57

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

11% less capital invested

Capital invested by funds: $1.01B → $899M (-$108M)

83% less call options, than puts

Call options by funds: $7.01M | Put options by funds: $40.8M

Holders
175
Holders Change
+8
Holders Change %
+4.79%
% of All Funds
4.38%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
28
Increased
59
Reduced
57
Closed
18
Calls
$7.01M
Puts
$40.8M
Net Calls
-$33.8M
Net Calls Change
-$26.8M

Top Buyers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
+$14.3M
2
BFA
BlackRock Fund Advisors
California
+$12.4M
3
SCM
Scopia Capital Management
New York
+$6.5M
4
SM
Sabby Management
Florida
+$5.23M
5
Millennium Management
Millennium Management
New York
+$4.83M

Top Sellers

Rank Fund Capital Flow
1
EAM
Eagle Asset Management
Florida
-$13.7M
2
Citadel Advisors
Citadel Advisors
Florida
-$10.8M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$8.44M
4
Goldman Sachs
Goldman Sachs
New York
-$7.54M
5
Westfield Capital Management
Westfield Capital Management
Massachusetts
-$7.43M
Name Holding Trade Value Shares
Change 		Change in
Stake
DAM
51
DLD Asset Management
New York
$2.55M +$2.68M +1,129 New
Invesco
52
Invesco
Georgia
$2.44M -$5.78M -2,433 -69%
BG
53
BlackRock Group
United Kingdom
$2.41M +$668K +281 +36%
Prudential Financial
54
Prudential Financial
New Jersey
$2.17M +$378K +159 +20%
NFA
55
Nationwide Fund Advisors
Ohio
$2.09M +$1.26M +530 +134%
QI
56
QS Investors
New York
$2.07M – – –
Susquehanna International Group
57
Susquehanna International Group
Pennsylvania
$1.95M +$2.05M +862 New
SEI Investments
58
SEI Investments
Pennsylvania
$1.73M +$330K +139 +22%
AIM
59
Alambic Investment Management
California
$1.72M +$968K +407 +115%
GC
60
Guggenheim Capital
Illinois
$1.71M -$464K -195 -20%
State of New Jersey Common Pension Fund D
61
State of New Jersey Common Pension Fund D
New Jersey
$1.69M – – –
California State Teachers Retirement System (CalSTRS)
62
California State Teachers Retirement System (CalSTRS)
California
$1.67M -$45.2K -19 -3%
AQR Capital Management
63
AQR Capital Management
Connecticut
$1.64M +$162K +68 +10%
Legal & General Group
64
Legal & General Group
United Kingdom
$1.5M +$725K +305 +84%
Swiss National Bank
65
Swiss National Bank
Switzerland
$1.43M – – –
Wellington Management Group
66
Wellington Management Group
Massachusetts
$1.4M -$8.44M -3,551 -85%
CCMH
67
Cornerstone Capital Management Holdings
New York
$1.39M -$808K -340 -36%
California Public Employees Retirement System
68
California Public Employees Retirement System
California
$1.29M -$395K -166 -22%
RhumbLine Advisers
69
RhumbLine Advisers
Massachusetts
$1.25M -$16.6K -7 -1%
MOACM
70
Mutual of America Capital Management
New York
$1.22M -$4.75K -2 -0.4%
GT
71
Glenmede Trust
Pennsylvania
$1.15M -$226K -95 -16%
CS
72
Candriam SCA
Luxembourg
$1.13M – – –
BA
73
BlackRock Advisors
Delaware
$1.12M -$102K -43 -8%
AllianceBernstein
74
AllianceBernstein
Tennessee
$1.12M -$61.8K -26 -5%
Walleye Trading
75
Walleye Trading
New York
$1.12M +$1.18M +498 New
1 2
3
4 5

ACOR Hedge Fund Activity: Q4 2016 in Review

175 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Acorda Therapeutics (ACOR) for Q4 2016, worth a combined $899M — down 11% from $1.01B a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new ACOR positions and 18 closed out — a net gain of 10 holders — while 59 added to existing stakes and 57 trimmed.

The largest buyer was Perceptive Advisors, opening a new position worth an estimated $14.3M. The largest seller was Eagle Asset Management, cutting an estimated $13.7M.

  • 175 institutional investors held Acorda Therapeutics (ACOR) as of Q4 2016, up from 167 in Q3 2016.
  • Funds reported $899M of Acorda Therapeutics stock for Q4 2016, down 11% quarter-over-quarter.
  • 28 funds opened new Acorda Therapeutics positions in Q4 2016 and 18 closed out, a net change of +10 holders.
  • The largest Acorda Therapeutics buyer in Q4 2016 was Perceptive Advisors, an estimated $14.3M added.
  • The largest Acorda Therapeutics seller in Q4 2016 was Eagle Asset Management, an estimated $13.7M sold.

Based on aggregated 13F filings for Q4 2016.